文献速递消化内镜消化道肿瘤与早癌

美国大型三级转诊中心结肠镜检查中实时计算机辅助息肉检测的性能与态度

Performance and attitudes toward real-time computer-aided polyp detection during colonoscopy in a large tertiary referral center in the United States.
PubMed 文献 · Gastrointest Endosc · 2023-02-18

在美国一家三级中心回顾性分析结肠镜检查数据库,比较实时计算机辅助检测(CADe)系统启用前后的息肉检出情况,并向内镜医师和员工发放匿名问卷调查态度。结果显示CADe启用率为52.1%,每例结肠镜检出腺瘤数(1.08 vs 1.04,P = .65)和腺瘤检出率等均无统计学显著差异,调查主要担忧为假阳性信号多(82.4%)、分散注意力(58.8%)和延长操作时间(47.1%)。

要点

  • CADe启用率为52.1%,是否启用由内镜医师决定。
  • 每例结肠镜检出腺瘤数与历史对照无统计学显著差异(1.08 vs 1.04,P = .65)。
  • 调查主要担忧为假阳性信号多(82.4%)、分散注意力(58.8%)和延长操作时间(47.1%)。

核心结论

  • 在基线腺瘤检出率高的内镜医师中,CADe在日常实践中未改善腺瘤检出。
  • 尽管CADe可用,仅约一半病例启用,员工和内镜医师提出多项担忧。
  • 未来研究将帮助阐明哪些患者和内镜医师最能从AI辅助结肠镜中获益。

研究设计与样本

  • 对前瞻性维护的结肠镜检查数据库进行回顾性分析。
  • 研究在美国一家三级中心开展,比较实时CADe系统可用前后的患者。
  • CADe系统是否启用由内镜医师自行决定。
  • 研究开始和结束时向内镜医师和员工发放匿名问卷调查态度。

主要发现

  • CADe启用率为52.1%。
  • 与历史对照相比,每例结肠镜检出腺瘤数无统计学显著差异(1.08 vs 1.04,P = .65)。
  • 排除诊断性和治疗性指征及未启用CADe的病例后,每例结肠镜检出腺瘤数仍无统计学显著差异(1.27 vs 1.17,P = .45)。
  • 腺瘤检出率、中位操作时间和退镜时间均无统计学显著差异。
  • 调查显示对AI辅助结肠镜态度不一,主要担忧为假阳性信号多(82.4%)、分散注意力程度高(58.8%)和认为延长操作时间(47.1%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Computer-aided detection (CADe) has been shown to improve polyp detection in clinical trials. Limited data exist on the impact, utilization, and attitudes toward artificial intelligence (AI)-assisted colonoscopy in daily clinical practice. We aimed to evaluate the effectiveness of the first U.S. Food and Drug Administration-approved CADe device for polyp detection in the United States and the attitudes toward its implementation. METHODS: We performed a retrospective analysis of a prospectively maintained database of patients undergoing colonoscopy at a tertiary center in the United States before and after a real-time CADe system was made available. The decision to activate the CADe system was at the discretion of the endoscopist. An anonymous survey was circulated among endoscopy physicians and staff at the beginning and conclusion of the study period regarding their attitudes toward AI-assisted colonoscopy. RESULTS: CADe was activated in 52.1% of cases. Compared with historical control subjects, there was no statistically significant difference in adenomas detected per colonoscopy (1.08 vs 1.04, P = .65), even after excluding diagnostic and therapeutic indications and cases where CADe was not activated (1.27 vs 1.17, P = .45). In addition, there was no statistically significant difference in adenoma detection rate (ADR), median procedure, and withdrawal times. Survey results demonstrated mixed attitudes toward AI-assisted colonoscopy, of which main concerns were high number of false-positive signals (82.4%), high level of distraction (58.8%), and impression it prolonged procedure time (47.1%). CONCLUSIONS: CADe did not improve adenoma detection in daily practice among endoscopists with high baseline ADRs. Despite its availability, AI-assisted colonoscopy was only activated in half of the cases, and multiple concerns were raised by staff and endoscopists. Future studies will help elucidate the patients and endoscopists that would benefit most from AI-assisted colonoscopy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Nehme F, Coronel E, Barringer DA, et al. Performance and attitudes toward real-time computer-aided polyp detection during colonoscopy in a large tertiary referral center in the United States. Gastrointest Endosc. 2023. PMID: 36801459. doi:10.1016/j.gie.2023.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。